Da yake taron shekara-shekara na 32 na Ƙungiyar Kula da Cututtukan Uro (CUA) zai gudana a Dalian, zan sake farawa, ina sake duba ilimin da na samu a baya game da cutar endoscopy ta fitsari. A duk tsawon shekarun da na yi ina amfani da endoscopy, ban taɓa ganin wani sashe ɗaya yana bayar da nau'ikan endoscope iri-iri ba, gami da na gani, na lantarki, da kuma takamaiman bayanai daban-daban. Bugu da ƙari, endoscope na fitsari suna ci gaba da bunƙasa cikin sauri, kuma a cikin gida, ana ba su sunaye masu ƙarfi kamar "cannonscope" da "cibiyar ɗaukar jiragen sama." Kwarewata ta farko da su abin mamaki ne. Na riga na tattara jerin bayyanar da nau'ikan endoscope masu sassauƙa da tauri, waɗanda ke aiki a matsayin ƙwarewar koyo mai mahimmanci ga aikina.
Kwanan nan, ina koyon duban fitsari ta hanyar amfani da sifili. Zan yi rikodinsa gwargwadon wurin da cutar ta samo asali. Kafin in koyi, zan fara fahimtar wasu bayanai na asali.
Bayanai da adadin tiyatar da ake buƙata don wasu yanayin urology
Yanzu haka an raba ilimin fitsari zuwa manyan hanyoyin fitsari (koda da mafitsara), ƙananan hanyoyin fitsari (mafitsara da prostate), da kuma andrology. Bugu da ƙari, tare da yawan tsufa, ana sa ran yawan cututtukan fitsari zai ƙaru. Tushen bayanai: Wani bincike da aka buga a cikin Rahoton Kimiyya ta Ƙungiyar Urology ta Asibitin Farko da ke da alaƙa da Jami'ar Soochow ya gudanar da cikakken bincike na farko game da nauyin BPH (benign prostatic hyperplasia) a duniya daga 1990 zuwa 2021 bisa ga bayanan GBD 2021. Wani bincike na rugujewar ƙwayoyin cuta ya tabbatar da cewa kashi 61% na ƙaruwar cutar a duniya ya faru ne saboda tsufar yawan jama'a, kashi 29% ga ƙaruwar yawan jama'a, da kuma kashi 10% ga canje-canjen cututtuka.
Ya zuwa ƙarshen shekarar 2024, yawan mutanen China masu shekaru 60 zuwa sama ya kai miliyan 310.31 (kimanin miliyan 310), wanda ya kai kashi 22.0% na jimillar yawan mutanen; daga cikinsu, yawan mutanen da suka kai shekaru 65 zuwa sama ya kai miliyan 220.23 (kimanin miliyan 220), wanda ya kai kashi 15.6% na jimillar yawan mutanen.
Ciwon daji na mafitsara (CA): Yana matsayi na farko a tsakanin cututtukan da ke shafar mafitsara, inda adadin kamuwa da cutar ya kai 13.42 ga kowace mutum 100,000. Dangane da birnin da ke da yawan jama'a miliyan 5, akwai sabbin mutane 671 da ke kamuwa da cutar a kowace shekara. A cewar bitar 2025 mai taken "Yanayin Cututtuka na Ciwon Daji, Halayen Halitta, da Umarnin Gaba don Ingantaccen Gudanarwa a China," kimanin kashi 54% na marasa lafiya a ƙasata suna da cutar da ta yi nisa a farkon ganewar cutar. Saboda haka, adadin marasa lafiya da ke da alamun tiyata ya kai kusan 671 * 0.46 = 308.
Ciwon daji na mafitsara: Adadin kamuwa da cutar shine 9.29 ga kowace mutum 100,000, tare da sabon adadin kamuwa da cutar a kowace shekara kusan 465 a cikin birni mai yawan jama'a miliyan 5. Dangane da bayanai na kan layi, idan aka yi la'akari da kashi 75% na NMIBC (Tis, Ta, T1), adadin sabbin kamuwa da cutar a kowace shekara tare da alamun tiyata shine 348. Ciwon daji na koda na Laparoscopic: Yawan kamuwa da cutar shine 7.37 ga kowace mutum 100,000, tare da sabon adadin kamuwa da cutar a kowace shekara kusan 368 a cikin birni mai yawan jama'a miliyan 5. Dangane da halayen cututtuka na "Nazarin Shekaru Goma kan Alaƙa tsakanin Yanayin Tiyata da Halayen Ciwon Kwayar Koda" wanda Asibitin Farko na Jami'ar Peking ya buga, matakin pT1 ya kai kashi 79.6%, wanda ya haifar da kimanin alamun tiyata na kimanin 293. Laparoscopic benign prostatic hyperplasia (BPH): Dangane da bayanan da ke sama, nan da shekarar 2024, za a sami mutane miliyan 310.31 a ƙasata masu shekaru 60 zuwa sama, waɗanda suka kai kashi 22.03% na yawan jama'a, wanda kusan kashi 48.73% maza ne (ku zo, maza, ba ku daɗe da rayuwa kamar mata). Yawan kamuwa da cutar BPH a cikin waɗanda suka kai shekaru 60 zuwa sama shine kashi 50%, wanda kashi 10% ke buƙatar tiyata. Adadin mutanen da ke buƙatar maganin BPH a cikin birni mai yawan jama'a miliyan 5 shine: miliyan 5 * 22.03% * 48.73% * 50% * 10% ≈ mutane 26,838, wanda hakan yayi yawa.
Duwatsun fitsari: Babu wani bayani a hukumance da ake da shi. Dangane da kashi 5% na yawan kamuwa da cutar, kashi 25% na buƙatar tiyata. A cikin birni mai yawan jama'a miliyan 5, yawan kamuwa da cutar da kuma maganinta a kowace shekara shine kimanin 62,500, wanda hakan ya yi yawa. Tabbas, wannan shine babban iyaka. Ana amfani da lithotripsy na waje, lithotripsy na laser ureteroscopic, da kuma nephrolithotomy na percutaneous tare da lithotripsy na pneumatic (laser).
Daga sama zuwa ƙasa ta wurin yanayin jiki
Ciwon nephrolithotomy na Percutaneous
Aikin tiyatar nephrolithotomy na Percutaneous (PCNL) wani tsari ne mai ƙarancin shiga jiki wanda ke ƙirƙirar hanyar shiga fata don magance duwatsun koda ko raunuka. Ana amfani da shi musamman don magance manyan duwatsun koda (>2 cm) ko masu rikitarwa. Babban fa'idodinsa sun haɗa da ƙarancin rauni, murmurewa cikin sauri, da kuma yawan tsarkake duwatsu. Na'urorin Nephroscopes suna ƙara ƙanƙanta a diamita, tare da tashoshi na yau da kullun (24-30 Fr), ƙananan tashoshi (16-22 Fr), da tashoshi na ultrafine (<16 Fr). Kayan aikin lithotripsy masu siffar allura waɗanda diamita kusan 1.4 mm suma suna samuwa yanzu. Percutaneous nephrolithotomy kayan aiki ne na yau da kullun a cibiyoyin lithotripsy na urological.
Na'urar hangen nesa ta gefen fata tana da filin kallon 12°, murfin elliptical, diamita na waje na 8.5 Fr/12 Fr, tsawon aiki mai inganci na kimanin mm 250, da kuma hanyar aiki na kimanin Fr 6.
Mu, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., kamfani ne da ke kera kayayyaki a China, wanda ya ƙware a fannin amfani da endoscopic, ya haɗa da layin GI kamar biopsy forceps, hemoclip, polyp snare, allurar sclerotherapy, catheter feshi, goge cytology, guidewire, kwandon dawo da dutse, catheter na magudanar ruwa na hanci da sauransu, waɗanda ake amfani da su sosai a cikin EMR, ESD, ERCP. Da kuma Urology Line, kamarrufin shiga ureteral tare da tsotsakumarufin shiga ureteral,Kwandon Maido da Dutse na Fitsari Mai Zafi, kumajagorar urologyda sauransu.
Kayayyakinmu an ba su takardar shaidar CE, kuma masana'antunmu an ba su takardar shaidar ISO. An fitar da kayayyakinmu zuwa Turai, Arewacin Amurka, Gabas ta Tsakiya da wani ɓangare na Asiya, kuma suna ba wa abokin ciniki yabo da yabo sosai!
Lokacin Saƙo: Satumba-22-2025